[google-translator]
Univdatos Whatsapp

Global Neurorehabilitation Devices Market is expected to foresee significant growth. North America leads the growth!

Global neurorehabilitation devices market is expected to register a CAGR of approx. 13% over the period of 2022-2028. Devices used to examine the brain and central nervous system are known as neurorehabilitation devices (CNS). Neurorobotic systems, non-invasive brain stimulators, neuro prosthetics, brain-computer interfaces, and wearable devices are some of the most commonly used devices. These tools support the patient’s diagnosis and management of a disease, disorder, or injury to the nervous system. They support the best recovery from neurological conditions like Parkinson’s disease and cardiovascular strokes as well as the relearning of motor skills. The growing demand for neurorehabilitation devices can be attributed to the Increase in the number of geriatric populations coupled with increased prevalence of age-related neurological disorders across the globe. For instance, according to WHO, the number and proportion of people aged 60 years and older in the population is increasing. In 2019, the number of people aged 60 years and older was 1 billion. This number will increase to 1.4 billion by 2030 and 2.1 billion by 2050. Owing to the glaring statistics, the rising geriatric mobility disorders are increasing the demand for neurorehabilitation devices and is anticipated to grow in the forthcoming years mainly. Moreover, the rising awareness among physicians with respect to these devices are fueling the demand for the neurorehabilitation devices market. Furthermore, the increase in research and development in neurorehabilitation devices, and the rise in adoption rate for neurorehabilitation devices by both patients and prescribers are expected to drive the market for neurorehabilitation devices market in the coming years.


Request for Sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=31094


Based on the products, the neurorehabilitation devices market is segmented into neuro-robotic devices, wearable devices, brain-computer interface, and brain stimulators. The neuro-robotic devices segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Neurorobotics systems are based on central nervous system principles. The recent advancements in this area, such as exoskeletons and prosthetics, are a key propellant for neurorobotics.

Based on the therapy area, the market is fragmented into stroke, multiple sclerosis, Parkinson’s disease, cerebral palsy, and others. The stroke segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Stroke kills brain cells by cutting off the blood and nutrient supply. Strokes can have a variety of effects, including movement impairment, sensory impairment, cognitive impairment, and visual impairment. Stroke was the second global cause of death across the world and the leading cause of disability


For a detailed analysis of the Global Neurorehabilitation Devices Market browse throughhttps://univdatos.com/report/neurorehabilitation-devices-market/


For a better understanding of the market adoption of neurorehabilitation devices market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the neurorehabilitation devices industry owing to the increasing incidence rate of neurological diseases, the increasing geriatric population, and sophisticated and equipped healthcare infrastructure in comparison with the other regions.

Some of the major players operating in the market include Hocoma AG, Bionik Laboratories Corp., Abbott Laboratories, Ectron Ltd., Medtronic, Ekso Bionics Holdings Inc, Boston Scientific Corporation, Tyromotion GmbH, Helius Medical Technologies, Neurorehabilitation Robotics Ltd.


Global Neurorehabilitation Devices Market Segmentation


Market Insight, by Product

  • Neuro-Robotic Devices
  • Wearable Devices
  • Brain-Computer Interface
  • Brain stimulators


Market Insight, by Therapy Area

  • Stroke
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Cerebral Palsy
  • Others


Market Insight, by End-Users

  • Hospitals/Clinics
  • Cognitive Care Centers
  • Others


Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Australia
    • Japan
    • Rest of Asia-Pacific
  • Rest of World


Top Company Profiles

  • Hocoma AG
  • Bionik Laboratories Corp.
  • Abbott Laboratories
  • Ectron Ltd.
  • Medtronic
  • Ekso Bionics Holdings Inc
  • Boston Scientific Corporation
  • Tyromotion GmbH
  • Helius Medical Technologies
  • Neurorehabilitation Robotics Ltd